{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:02:08Z","timestamp":1791147728101,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":4962,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1111\/j.1600-6143.2009.02618.x","type":"journal-article","created":{"date-parts":[[2009,4,16]],"date-time":"2009-04-16T14:42:20Z","timestamp":1239892940000},"page":"1214-1222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":255,"title":["Cell-Mediated Immunity to Predict Cytomegalovirus Disease in High-Risk Solid Organ Transplant Recipients"],"prefix":"10.1016","volume":"9","author":[{"given":"D.","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Chernenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Moussa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Cobas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Manuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Preiksaitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Venkataraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Humar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2009.02618.x_bib1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-6143.2005.01207.x","article-title":"AST ID Working Group on Infectious Disease Monitoring. American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation.","volume":"6","author":"Humar","year":"2006","journal-title":"Am J Transplant"},{"issue":"s10","key":"10.1111\/j.1600-6143.2009.02618.x_bib2","first-page":"51","article-title":"Cytomegalovirus.","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib3","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1600-6143.2004.00382.x","article-title":"Valganciclovir Solid Organ Transplant Study Group Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients.","volume":"4","author":"Paya","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib4","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1056\/NEJM199905133401903","article-title":"International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation.","volume":"340","author":"Lowance","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib5","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0140-6736(97)05535-9","article-title":"The Oral Ganciclovir International Transplantation Study Group. Randomized trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients.","volume":"350","author":"Gane","year":"1997","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib6","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1056\/NEJMra064928","article-title":"Infection in solid-organ transplant recipients.","volume":"357","author":"Fishman","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib7","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1600-6143.2004.00505.x","article-title":"Cytomegalovirus and lung transplantation.","volume":"4","author":"Zamora","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib8","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1111\/j.1600-6143.2006.01413.x","article-title":"Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients","volume":"6","author":"Khoury","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib9","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.tp.0000226071.12562.1a","article-title":"Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis","volume":"81","author":"Limaye","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib10","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1097\/01.ASN.0000030141.41726.52","article-title":"Predominance of virus specific CD8 T cells in human primary cytomegalovirus infection","volume":"13","author":"Sester","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib11","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S1473-3099(04)01202-2","article-title":"Human cytomegalovirus: Clinical aspects, immune regulation, and emerging treatments","volume":"4","author":"Gandhi","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib12","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10875-005-5372-8","article-title":"T cell control of primary and latent cytomegalovirus infections in healthy subjects","volume":"25","author":"Lidehall","year":"2005","journal-title":"J Clin Immunol"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib13","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1084\/jem.20042384","article-title":"Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells.","volume":"201","author":"Bunde","year":"2005","journal-title":"J Exp Med"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1600-6143.2003.00647.x","article-title":"Cellular immune responses to cytomegalovirus in renal transplant recipients","volume":"5","author":"Radha","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib15","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.4049\/jimmunol.176.4.2625","article-title":"Persistent cytomegalovirus-specific memory responses in the lung allograft and blood following primary infection in lung transplant recipients.","volume":"176","author":"Shlobin","year":"2006","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib16","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1182\/blood.V98.5.1358","article-title":"Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection","volume":"98","author":"Gratama","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib17","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1182\/blood-2003-06-1937","article-title":"Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8 +cytotoxic T-cell response in natural infection.","volume":"104","author":"Manley","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib18","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.20050882","article-title":"Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed","volume":"202","author":"Sylwester","year":"2005","journal-title":"J Exp Med"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib19","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1128\/JVI.77.9.5226-5240.2003","article-title":"Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers.","volume":"77","author":"Elkington","year":"2003","journal-title":"J Virol"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1399-3062.2006.00199.x","article-title":"Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON-CM.","volume":"9","author":"Walker","year":"2007","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1600-6143.2007.02026.x","article-title":"A survey of CMV prevention strategies after liver transplantation.","volume":"8","author":"Levitsky","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib22","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1097\/01.tp.0000204048.90367.97","article-title":"24-week oral ganciclovir prophylaxis in kidney recipients is associated with reduced symptomatic cytomegalovirus disease compared to a 12-week course","volume":"81","author":"Doyle","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib23","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/j.1600-6143.2004.00571.x","article-title":"Following universal prophylaxis with intravenous ganciclovir and cytomegalovirus immune globulin, valganciclovir is safe and effective for prevention of CMV infection following lung transplantation.","volume":"4","author":"Zamora","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib24","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jcv.2005.10.014","article-title":"Cytomegalovirus infection in solid organ transplant recipients: New challenges and their implications for preventive strategies","volume":"35","author":"Singh","year":"2006","journal-title":"J Clin Virol"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib25","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1600-6143.2004.00391.x","article-title":"Clinical utility of cytomegalovirus viral load testing for predicting CMV disease in D+\/R\u2212 solid organ transplant recipients.","volume":"4","author":"Humar","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib26","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1600-6143.2005.00797.x","article-title":"Valganciclovir Solid Organ Transplant Study Group. Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+\/R\u2212 transplant recipients","volume":"5","author":"Humar","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1399-3062.2004.00056.x","article-title":"T-helper cell responses in liver transplant recipients: Correlation with cytomegalovirus and other major infections.","volume":"6","author":"Singh","year":"2004","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib28","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1097\/00007890-200105150-00018","article-title":"Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation","volume":"71","author":"Sester","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib29","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1600-6143.2008.02191.x","article-title":"Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation.","volume":"8","author":"Mattes","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib30","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/511307","article-title":"Longitudinal assessment of cytomegalovirus (CMV)-specific immune responses in liver transplant recipients at high risk for late CMV disease.","volume":"195","author":"La Rosa","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1086\/314879","article-title":"Cytomegalovirus (CMV)-specific T cell immunity after renal transplantation mediates protection from CMV disease by limiting the systemic virus load.","volume":"180","author":"Reusser","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib32","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1086\/591185","article-title":"Patterns of cytomegalovirus reactivation are associated with distinct evolutive profiles of immune reconstitution after allogeneic hematopoietic stem cell transplantation","volume":"198","author":"Moins-Teisserenc","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1479-5876-6-29","article-title":"Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients.","volume":"6","author":"Egli","year":"2008","journal-title":"J Transl Med"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib34","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1182\/blood.V99.10.3830","article-title":"Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation","volume":"99","author":"Hebart","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1600-6143.2009.02618.x_bib35","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1111\/j.1600-6143.2008.02294.x","article-title":"Linking CMV serostatus to episodes of CMV reactivation following lung transplantation by measuring CMV-specific CD8+ T-cell immunity.","volume":"8","author":"Westall","year":"2008","journal-title":"Am J Transplant"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2009.02618.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522016847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522016847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2009.02618.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:46:56Z","timestamp":1761626816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522016847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S1600613522016847"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2009.02618.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell-Mediated Immunity to Predict Cytomegalovirus Disease in High-Risk Solid Organ Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2009.02618.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}